Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

Recruiting Observational Study
Immune Evasion, Tumor Pancreas Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The intricate interplay between systemic immunity and tumors profoundly influences not only the onset and progression of tumors but also serves as a crucial window into understanding tumor evolution and treatment status. This project aims to establish a large, multi-center pancreatic cancer cohort and a standardized clinical sample repository, capturing multimodal immunity big data on pancreatic c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Healthy individuals without benign or malignant liver, gallbladder, and pancreas diseases * Primary PDAC * Patients with benign pancreatic tumors * IPMN patients diagnosed by pathology/imaging Exclusion Criteria: * Having autoimmune diseases * Accompanied by other malignant …
Contacts

Yangyang Wang

13957830918

12418635@zju.edu.cn

CONTACT